Inovio Pharmaceuticals Q2 EPS $(0.07) Beats $(0.22) Estimate

Bet on 5 Top-Ranked Stocks With Rising P/E

The article explores how rising P/E ratios, combined with accelerating earnings growth and sustained price momentum, can indicate strong investment opportunities. Five stocks meeting these criteria are highlighted: CuriosityStream (CURI), Inovio Pharmaceuticals (INO), GDS Holdings (GDS), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI). These companies demonstrate consistent price gains relative to the S&P 500 and positive earnings trends.

World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report

Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3

Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.

Inovio Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS results.